- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02020642
Effect of Renal Transplantation on Obstructive Sleep Apnea in End Stage Renal Disease Patients (SASinTx) (SASinTx)
Prospective Interventional Study Investigating the Effect of Renal Transplantation on Obstructive Sleep Apnea and Its Correlation to Nocturnal Rostral Fluid Shift, in End Stage Renal Disease Patients
Study Overview
Status
Intervention / Treatment
Detailed Description
Obstructive sleep disordered breathing is more prevalent in end stage kidney disease patients than in the general population, and may participate to the increased cardiovascular mortality observed in this group of patients. Despite a significant increase in knowledge about the harmful effects of obstructive sleep apnea, the pathophysiological mechanisms are poorly understood. Recent observations suggest a causative relationship between overnight fluid displacement from the legs to the neck soft and the severity of obstructive sleep apnea. This mechanism was demonstrated in otherwise healthy subjects, in heart failure patients, and in patients with venous insufficiency. We thus suspect that this pathophysiologic mechanism could explain the increased prevalence of obstructive sleep apnea in patients with fluid overload, including chronic renal failure.
The purpose of this study is to investigate the effect of renal transplantation on fluid overload and its consequence on the severity of obstructive sleep apnea, in patients with end stage chronic kidney disease. It aims further to investigate the relationship between overhydration, nocturnal rostral fluid shift and the severity of sleep apnea.
The severity of obstructive sleep apnea is measured by two attended polysomnographies, a baseline PSG performed before and a follow-up PSG performed 6 month after renal transplantation. Overhydration and leg fluid are evaluated by bioimpedance, performed at the beginning and at the end of each polysomnography. Patients who are not already transplanted 6 months after the baseline PSG will be re-assessed and will be analyzed as control group.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Vaud
-
Lausanne, Vaud, Switzerland, 1011
- Centre d'Investigation et Recherche sur le Sommeil (CIRS) - Centre Hospitalier Universitaire Vaudois (CHUV)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- moderate to severe obstructive sleep apnea, with an apnea-hypopnea index (AHI) ≥ 15/h
- age ≥ 18 years
- patient with end stage renal disease on waiting list for a renal transplantation (cadaveric or live donor).
Exclusion Criteria:
- unstable congestive heart failure
- active psychiatric disease
- amputation of the lower limbs, proximal to the ankle
Study Plan
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Intervention Group
A baseline polysomnography (PSG) is performed at inclusion (before renal transplantation, Tx), followed by a post-Tx PSG 6 months after transplantation
|
Renal transplantation from cadaveric or live donor
|
|
NO_INTERVENTION: Control Group
A baseline polysomnography (PSG) is performed at inclusion, followed by a follow-up PSG at 6 months if the patient is not already transplanted
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reduction of the obstructive sleep apnea severity
Time Frame: six months after renal transplantation
|
Reduction of the obstructive sleep apnea severity, measured by attended polysomnography, six months after renal transplantation
|
six months after renal transplantation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reduction in nocturnal leg fluid volume shift between the legs and the neck
Time Frame: six months after renal transplantation
|
Reduction in nocturnal leg fluid volume shift between the legs and the neck, measured by bioimpedance and neck circumference six months after renal transplantation
|
six months after renal transplantation
|
|
Relationship between overhydration, leg fluid volume shift, ankle and neck circumference and the severity of obstructive sleep apnea
Time Frame: at baseline and six months after renal transplantation
|
Relationship between overhydration (measured by bioimpedance), leg fluid volume shift, ankle and neck circumference and the severity of obstructive sleep apnea
|
at baseline and six months after renal transplantation
|
|
Change in the severity of the periodic limb movement disorder (PLMD)
Time Frame: six months after renal transplantation
|
Change in the severity of the periodic limb movement disorder (PLMD)
|
six months after renal transplantation
|
|
Change in the severity of central sleep apnea
Time Frame: six months after renal transplantation
|
Change in the severity of central sleep apnea
|
six months after renal transplantation
|
Collaborators and Investigators
Investigators
- Principal Investigator: Rapahël Heinzer, MD, Centre d'Investigation et Recherche sur le Sommeil (CIRS) - Centre Hospitalier Universitaire Vaudois (CHUV)
- Principal Investigator: Valentina Forni Ogna, MD, Service de Néphrologie et Hypertension - Centre Hospitalier Universitaire Vaudois (CHUV)
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Nervous System Diseases
- Respiratory Tract Diseases
- Respiration Disorders
- Sleep Disorders, Intrinsic
- Dyssomnias
- Sleep Wake Disorders
- Urologic Diseases
- Renal Insufficiency
- Signs and Symptoms, Respiratory
- Renal Insufficiency, Chronic
- Sleep Apnea Syndromes
- Sleep Apnea, Obstructive
- Kidney Diseases
- Apnea
- Kidney Failure, Chronic
Other Study ID Numbers
- CIRS-SASinTx
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obstructive Sleep Apnea
-
Hospital Felicio RochoNot yet recruitingSleep Apnea/Hypopnea Syndrome | Sleep Apnea Syndrome, Obstructive | Sleep Apnea Syndrome (OSAS) | Sleep Apnea - Obstructive
-
Isabel Moreno HayAmerican Academy of Dental Sleep MedicineRecruitingObstructive Sleep Apnea (SAOS) | Obstructive Sleep Apnea (OSAS)United States
-
Mayo ClinicEnrolling by invitationObstructive Sleep Apnea | OSA | Obstructive Sleep Apnea (OSA)United States
-
Mardin Artuklu UniversityNot yet recruitingObstructive Sleep Apnea | Sleep ApneaTurkey (Türkiye)
-
Yale UniversityNational Heart, Lung, and Blood Institute (NHLBI); ResMed FoundationRecruitingObstructive Sleep Apnea | Sleep ApneaUnited States
-
Hospices Civils de LyonNot yet recruitingObstructive Sleep ApneaFrance
-
University Hospital, AntwerpNot yet recruiting
-
Nyxoah Inc.Not yet recruitingObstructive Sleep ApneaUnited States
-
Restera, Inc.RecruitingObstructive Sleep ApneaAustralia
Clinical Trials on Renal transplantation
-
Bakirkoy Dr. Sadi Konuk Research and Training HospitalCompleted
-
Ankara City Hospital BilkentNot yet recruitingHypotension | Renal Transplant Failure and RejectionTurkey
-
University Hospital, MontpellierTerminatedChronic Renal Failure Requiring HemodialysisFrance
-
Patrick SchjelderupAarhus University HospitalRecruitingKidney Transplantation | Living Donors | Senescence | Renal Fibrosis | Multiparametric Magnetic Resonance ImagingDenmark
-
Mayo ClinicRecruitingChronic Kidney Diseases | Transplant | Neurogenic Bladder | Bladder Outlet Obstruction | Bladder Dysfunction | Bladder Exstrophy | Bladder Absence | Posterior Urethral Valve | Failure, KidneyUnited States
-
Hospices Civils de LyonUnknown
-
Wake Forest University Health SciencesStanford UniversityCompletedRenal Transplant | Rejection Acute Renal | Rejection Chronic Renal | Rejection of Renal Transplant | Renin-Angiotensin SystemUnited States
-
Tulane UniversityRecruitingEnd Stage Renal Disease | Human Immunodeficiency VirusUnited States
-
Ayman Al Jurdi, MDTonix Pharmaceuticals, Inc.Not yet recruitingImmunosuppression | Kidney Transplant | Kidney Transplant Failure and Rejection | Immunosuppression After Kidney TransplantationUnited States
-
Hospices Civils de LyonCompletedKidney Transplantation | Pancreas-kidney TransplantationFrance